Research article · 25 Aug 2026
Conference abstractPublished 18 Aug 2016
Universally protective synthetic vaccines: The holy grail in modern vaccinology
Univac NV, Belgium
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
To eliminate safety risks related to infectivity, inactivated pathogens and more suitably, well-characterized pathogen derived antigens (Ags) have increasingly been used as immunogens in âÂ?Â?modernâÂ?Â? vaccines. The selection of these Ags is usually based on their capacity to naturally induce immune responses that âÂ?Â?correlateâÂ?Â? with protection. These Ags, however, are known to be antigenically variable (e.g., conformational Bc epitopes) and/or subject to immunogenetic restriction (e.g., linear, Tc epitopes). In addition, the immunogenicity of âÂ?Â?goodâÂ?Â? vaccinal Ags is largely dependent on memory CD4+ T helper cells. However, activation of the latter upon natural infection or foreign Ag exposure of genetically predisposed subjects can occasionally lead to immune pathology. Priming of CD4+ T helper cells by adjuvanted vaccines is, therefore, increasingly raising safety concerns. On the other hand, Ags that are highly conserved and vulnerable because of their exposure on the surface of infected or pathologically altered host cells are not effectively or durably recognized by the host immune system and hence, not included in contemporary vaccines. Chemical polypeptide epitope synthesis combined with multimeric presentation of the selected polypeptide on a synthetic polyelectrolyte carrier enables Univac to develop novel and fully synthetic vaccines, the latter aim to prime âÂ?Â?Natural KillerâÂ?Â? cells that universally target vulnerable pathogen specific epitopes across a broad spectrum of different pathogen strains and host specific MHC allotypes.
Subjects
BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.
More from this journal
The newest in Current Synthetic and Systems Biology.
Commentary · 30 Dec 2025
Synthetic Organelles Driving Innovation in Biotechnology and
Opinion · 30 Dec 2025
XNAs And The Evolution Of Synthetic Genetic Design
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCurrent Synthetic and Systems Biology
- SubjectBiology
- BylineArticles whose byline prints “Geert Vanden Bossche”
